SCHEMBL17424071

SCHEMBL17424071

CCOCCc1cc(OC)c2[nH]cc(C(=O)OCC)c(=O)c2c1

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ CYP2C19 P33261 1/20 0.58
▸ GABRA1 P14867 4/20 0.51
▸ GABRB2 P47870 4/20 0.51
▸ CLEC4M Q9H2X3 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.47
▸ GABRB1 P18505 3/20 0.46
▸ GABRA3 P34903 3/20 0.46
▸ MAPT P10636 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17424075 0.89 ALDH1A1 (0.53) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL17424066 0.88 CYP1A2 (0.59) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL17424078 0.86 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL7284683 0.80 CYP1A2 (0.59) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL7290898 0.76 CYP1A2 (0.60) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL774558 0.76 CLEC4M (0.76) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL17424081 0.75 ALDH1A1 (0.55) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL7283152 0.75 GABRA1 (0.53) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL14845077 0.74 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C19GABRA1GABRB2
SCHEMBL7422721 0.74 CYP1A2 (0.58) CYP1A2CYP3A4CYP2C19GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3166930-A1 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE AS SELECTIVE LIGAND FOR CANNABINOID RECEPTOR 2 FOR DIAGNOSIS AND THERAPY ETH Zürich (CH) 2017-05-17 — — EP disclosed
WO-2016005419-A1 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE AS SELECTIVE LIGAND FOR CANNABINOID RECEPTOR 2 FOR DIAGNOSIS AND THERAPY ETH ZURICH (CH) 2016-01-14 — — WO disclosed
Send feedback